Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

NCT01051570 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: carboplatin
DRUG: RAD 001
DRUG: prednisone
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]